Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 21 Dec 2022 |
2 | Reply to Exam Report (MIS-R) | 10 Jun 2023 |
3 | TM-M(EXTENSION OF TIME) | 30 Mar 2024 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 18 Jul 2024 |
5 | Journal Copy | 23 Aug 2024 |
1 | EXAMINATION REPORT | 15227790 | 11 May 2023 | |
2 | Hearing Notice (Show Cause) | 17624556 | 05 Mar 2024 | |
3 | Hearing Notice (Show Cause) | 18333816 | 18 Jun 2024 | |
4 | Tribunal Accepted Notice for : 5732079 | 18549029 | 6824844 | 22 Jul 2024 |
Trademark was applied on 21 December 2022 with IP India.
Proprietor of Promaydine is AKUMS DRUGS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Promaydine is Accepted & Advertised.
Application number alloted to the trademark is 5732079.
Trademark has been filed in the following category:
WORD